scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1000339685 |
P356 | DOI | 10.1007/BF01309880 |
P698 | PubMed publication ID | 3013134 |
P2093 | author name string | K Nishiyama | |
R Mori | |||
T Eto | |||
N Ohtomo | |||
Y Kino | |||
P2860 | cites work | Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity. | Q33901808 |
Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice | Q33906859 | ||
Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection | Q34123889 | ||
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING | Q36266931 | ||
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 | Q36333640 | ||
Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection | Q36335255 | ||
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. | Q36431330 | ||
Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity | Q36495307 | ||
Herpes Simplex Virus Glycoprotein gA/B: Evidence that the Infected Vero Cell Products Comap and Arise by Proteolysis | Q36925000 | ||
Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. | Q37099580 | ||
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells | Q37500512 | ||
Herpes Simplex Virus Glycoproteins: Participation of Individual Herpes Simplex Virus Type 1 Glycoprotein Antigens in Immunocytolysis and Their Correlation with Previously Identified Glycopolypeptides | Q37601617 | ||
Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2 | Q39458271 | ||
Defective in vitro lymphoproliferative responses to herpes simplex virus in patients with frequently recurring herpes infections during the disease-free interval | Q40182907 | ||
Preparation and efficacy of an inactivated subunit vaccine (NFUI BHK) against type 2Herpes simplex virus infection | Q40191228 | ||
Mechanism of Acquired Resistance to Herpes Simplex Virus Infection as Studied in Nude Mice | Q40286224 | ||
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1 | Q41179042 | ||
Difference in age distribution of antibody to herpes simplex virus in Fukuoka, Manila and Busan | Q43323079 | ||
Enhanced HSV Recovery from Neuronal Tissues of Latently Infected Rabbit | Q43797420 | ||
The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity | Q45793505 | ||
An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D | Q45798863 | ||
Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice | Q45801958 | ||
Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. | Q45804968 | ||
Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice | Q45811007 | ||
Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus | Q45838593 | ||
Immune response to a DNA free herpes simplex vaccine in man | Q72956055 | ||
P433 | issue | 1-4 | |
P1104 | number of pages | 12 | |
P304 | page(s) | 69-80 | |
P577 | publication date | 1986-01-01 | |
P1433 | published in | Archives of Virology | Q2860564 |
P1476 | title | Immunogenicity of purified glycoprotein gB of herpes simplex virus | |
P478 | volume | 89 |
Q36527580 | Developments in herpes simplex virus vaccines: old problems and new challenges |
Q45850884 | Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2. |
Q36884382 | Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells |
Q34340404 | Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection |
Q36626491 | Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. |
Q35271194 | Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models |
Q69821212 | Zwitterionic detergent solubilisation of HSV-1 surface antigens |
Search more.